A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO2 models of experimental human anxiety
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Abstract Studies in human volunteers that can demonstrate proof of concept are attractive in that possible mechanisms and potential new drug treatments can be examined. We have been developing models of anxiety disorders using the inhalation of 7.5% CO 2 for 20 min to model generalised anxiety disorder, as well as using the previously reported 35% CO 2 as a model for panic anxiety. In a double-blind, placebo-controlled, three-way crossover study in 12 healthy volunteer subjects, we compared a full agonist at the benzodiazepine receptor that binds to four α-subtypes of the receptor (α-1,-2,-3,-5) (alprazolam 1 mg), with zolpidem (5 mg), an agonist selective for the α-1 subtype of the gamma amino butyric acid-receptor subtype A (GABA-A) receptor, which is a widely used hypnotic drug. Compared with placebo, both drugs significantly attenuated peak CO 2-induced changes in subjective feelings after the inhalation of 7.5% CO 2 for 20 min. However, there were fewer significant differences after a single vital capacity inhalation of 35% CO 2, where zolpidem was less efficacious than alprazolam at reducing CO 2-induced symptoms. In conclusion, our results show that zolpidem shows some anxiolytic efficacy in the 7.5% CO 2 model, similar to alprazolam, and this is the first report of such an effect of zolpidem in a model of anxiety. These and other studies of benzodiazepines in clinical and volunteer studies suggest a definite role of the GABA-A receptor in CO 2-induced anxiety, and it would be of interest to examine other GABA-A receptor subtype selective drugs, which are now in early phase clinical studies and are showing selective efficacy in pharmacodynamic studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H. (1999) · Nature · doi:10.1038/44579 · Cited by 1,172
McKernan, R. M., Rosahl, T. W., Reynolds, D. S., Sur, C., Wafford, K. A., Atack, J. R., Farrar, S., Myers, J., Cook, G., Ferris, P., et al. (2000) · Nature Neuroscience · doi:10.1038/75761 · Cited by 944
Dias, R., Sheppard, W. F. A., Fradley, R. L., Garrett, E. M., Stanley, J. L., Tye, S. J., Goodacre, S., Lincoln, R. J., Cook, S. M., Conley, R., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1166-05.2005 · Cited by 247
de Haas, S. L., de Visser, S. J., van der Post, J. P., de Smet, M., Schoemaker, R. C., Rijnbeek, B., Cohen, A. F., Vega, J. M., Agrawal, N. G. B., Goel, T. V., et al. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106072343 · Cited by 84
Comparative pharmacokinetics of alprazolam and lorazepam in humans and in African Green Monkeys
Friedman, H., Redmond, D. E., & Greenblatt, D. J. (1991) · Psychopharmacology · doi:10.1007/bf02244562 · Cited by 24
Cited by
Bandelow, B., Baldwin, D., Abelli, M., Bolea-Alamanac, B., Bourin, M., Chamberlain, S. R., Cinosi, E., Davies, S., Domschke, K., Fineberg, N., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1190867 · Cited by 347
“Both alprazolam (1 mg) and the partial benzodiazepine receptor antagonist zolpidem (5 mg) attenuated subjective anxiety in healthy volunteers after 20 min of 7.5% CO2 inhalation (Bailey et al. 2009).”
BackgroundInfluentialSelf-citationSearching for perfect sleep: the continuing evolution of GABA A receptor modulators as hypnotics
Nutt, D. J., & Stahl, S. M. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109106927 · Cited by 163
“A single recent study of zolpidem in a CO2-induced model of generalized anxiety disorder (GAD) in human volunteers demonstrated some anxiolytic efficacy of zolpidem, although this was less than that seen with a nonselective benzodiazepine (Bailey et al., 2009).”
BackgroundSelf-citationEvaluating psychological interventions in a novel experimental human model of anxiety
Ainsworth, B., Marshall, J. E., Meron, D., Baldwin, D. S., Chadwick, P., Munafò, M. R., & Garner, M. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.02.001 · Cited by 28
Emerging drugs for panic disorder
Perna, G., Guerriero, G., & Caldirola, D. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.628313 · Cited by 23
“Similarly, the GABA system influences activity of several sites involved in autonomic, respiratory and behavioral responses, including brainstem, hypothalamus and limbic structures [23].”
Background
Metadata
- Authors
- Bailey, J., Papadopoulos, A., Seddon, K., & Nutt, D.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2008-05-30
- Volume
- 23
- Issue
- 2
- Pages
- 117-122
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2150272889
- Cited by
- 46
- References
- 5
- FWCI
- 6.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.